Pune-based molecular diagnostics company Mylab Discovery Solutions on Monday said it has received commercial approval from the Central Drugs Standard Control Organisation (CDSCO) for its COVID-19 test kit.
The test kit by the company is the first ‘Made in India’ kit to receive commercial approval from CDSCO, and is named as Mylab PathoDetect COVID-19 Qualitative PCR kit, the company said in a statement.
“With emphasis on ‘Make in India’ and support from local and central government, the COVID- 19 kit has been made as per WHO/CDC guidelines. It was developed and evaluated in a record time,” Mylab Discovery Solutions MD Hasmukh Rawal said.
Local sourcing of test kits will be a major breakthrough for India as the testing kit by Mylab would cost nearly one-fourth of the current procurement cost, the company said. Moreover, Mylab’s COVID-19 test kit screens and detects the infection within 2.5 hours as compared with over 7 hours taken by current protocols, it added.
Coronavirus pandemic has become a matter of concern as the number of cases continues to rise. India, the number of cases will be soon crossing the 500 mark and the nation has been witnessing complete lockdown in lieu of the distressing situation.